[REGN] QoQ Quarter Result on 30-Sep-2014 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
04-Nov-2014
Financial Year
2014
Quarter
30-Sep-2014 [#Q3]
Profit Trend
QoQ- -14.03%
YoY- -43.58%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
Revenue 998,617 869,612 802,329 725,788 665,700 625,740 610,412 38.96%
PBT 327,996 276,523 221,287 176,078 203,119 175,263 198,153 40.05%
Tax 133,353 200,502 111,111 96,358 110,384 109,820 101,347 20.13%
NP 194,643 76,021 110,176 79,720 92,735 65,443 96,806 59.50%
Tax Rate -40.66% -72.51% -50.21% -54.72% -54.34% -62.66% -51.15% -
Total Cost 803,974 793,591 692,153 646,068 572,965 560,297 513,606 34.92%
Ratio Analysis
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
NP Margin 19.49 8.74 13.73 10.98 13.93 10.46 15.86 14.77%
Per Share
30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 31/12/13 CAGR
EPS 1.89 0.74 0.89 0.83 0.96 0.69 0.98 55.12%
EPS Diluted 1.69 0.66 0.79 0.73 0.85 0.61 0.73 75.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.